NXGL Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: April 03, 2026
Report Source: 2025 Annual Report
Nexgel Inc. Stock Analysis NXGL
NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania and currently employs 19 full-time employees. The company went IPO on 2021-12-22. The company is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The firm operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises is comprised of the CGN JV used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George. The company also holds a portfolio of regenerative biomaterials which include Biovance, Biovance 3L, Natalin, and others.
Read More Nexgel Inc (NXGL) Chart
Key Statistics of Nexgel Inc (NXGL)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.54Volume
130.20KP/E Ratio (TTM)
-52 Week Range
Market Cap
6.75MAvg. Volume
355.05KDividend Yield
-Financial Metrics & Statements of Nexgel Inc (NXGL)
FAQ's for Nexgel Inc (NXGL)
- According to Musaffa’s Shariah screening methodology, Nexgel Inc (NXGL) is currently classified as HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.